Redeye provides an initial take following Paxman’s Q1 2026 report. The report was in line with our expectations and, overall, we consider it solid. We believe a modestly positive share price reaction is justified during the day. We will return with a research update, where we currently do not anticipate any material changes to our estimates or fair value range.
LÄS MER
